Underactive immune response may explain obesity link to COVID-19 severity
Individuals who are obese may be more susceptible to severe COVID-19 because of a poorer inflammatory immune response, say Cambridge scientists.
Mar 20, 2023
0
52
Individuals who are obese may be more susceptible to severe COVID-19 because of a poorer inflammatory immune response, say Cambridge scientists.
Mar 20, 2023
0
52
The rate of cardiac arrest during delivery hospitalizations is 13.4 per 100,000, with cardiac arrest occurring more often among older patients, non-Hispanic Blacks, and those with an underlying medical condition, according ...
Mar 14, 2023
0
51
Recently, a team led by Prof. DU Jiangfeng from the Key Laboratory of Microscale Magnetic Resonance of Chinese Academy of Sciences (CAS) developed a new method for deep electrical impedance tomography reconstruction without ...
Feb 27, 2023
0
9
Studies from animal models suggest that frequent alcohol consumption may lead to an increased risk of COVID-19 infection and present a potential for complications in disease progression.
Feb 20, 2023
0
14
Scientists at the Francis Crick Institute have uncovered how cells lining the lung airways change their metabolism, and how this process is key to helping the lungs heal after infection or damage.
Feb 13, 2023
0
97
COVID was Australia's third leading cause of death (after heart disease and dementia) in 2022. In a bad flu year we have about 1,200 influenza deaths. We had more than 1,500 COVID deaths in just the first month of 2023. We ...
Jan 31, 2023
0
1
A group of scientists say they've created a safer version of fentanyl that could potentially diminish the drug's addictive side effects, which have resulted in annual deaths of tens of thousands of people across the United ...
Jan 23, 2023
0
12
A novel peptide designed by University of California, Irvine researchers has been found to suppress the damaging lung inflammation seen in acute respiratory distress syndrome, or ARDS. The study, which appears in iScience, ...
Jan 17, 2023
0
40
A new study in the journal Nature Communications reveals how a viral toxin produced by the SARS-CoV-2 virus may contribute to severe COVID-19 infections.
Dec 9, 2022
1
92
Researchers at The Tisch Cancer Institute uncovered inflammatory markers that may predict which COVID-19 patients are more likely to respond to therapies like the anti-cancer drug pacritinib, according to phase 2 trial results ...
Dec 5, 2022
0
7